The ever-expanding myokinome: discovery challenges and therapeutic implications (Q38951385)

7 September 2017

1 reference

title

The ever-expanding myokinome: discovery challenges and therapeutic implications (English)

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mark A Febbraio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

12 September 2016

1 reference

Nature Reviews Drug Discovery

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

719-729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27616294%20AND%20SRC:MED&resulttype=core&format=json

Muscles, exercise and obesity: skeletal muscle as a secretory organ

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Integrative biology of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise counteracts the effects of short-term overfeeding and reduced physical activity independent of energy imbalance in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interactions between energy surplus and short-term exercise on glucose and insulin responses in healthy people with induced, mild insulin insensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise and Regulation of Adipokine and Myokine Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Identification of human exercise-induced myokines using secretome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A gene atlas of the mouse and human protein-encoding transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Cell-type-resolved quantitative proteomics of murine liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Systems proteomics of liver mitochondria function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Expression profiles of active genes in human and mouse livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The ABC's (and XYZ's) of peptide sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Introduction to mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Secretome profiling of primary human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Dynamics of the skeletal muscle secretome during myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Comparative proteomic analysis of the insulin-induced L6 myotube secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Deep proteomics of mouse skeletal muscle enables quantitation of protein isoforms, metabolic pathways, and transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Affinity prefractionation for MS-based plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Mapping the human plasma proteome by SCX-LC-IMS-MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Mass spectrometry of extracellular vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

CRISPR-Cas9-mediated genome editing and guide RNA design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

IL-4 acts as a myoblast recruitment factor during mammalian muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Suppression of body fat accumulation in myostatin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Adipose tissue browning and metabolic health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Evidence against a beneficial effect of irisin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Irisin - a myth rather than an exercise-inducible myokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The Structure of Irisin Reveals a Novel Intersubunit -Sheet Fibronectin Type III (FNIII) Dimer: IMPLICATIONS FOR RECEPTOR ACTIVATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

FGF21 is an Akt-regulated myokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Acute exercise induces FGF21 expression in mice and in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Fibroblast growth factor 21 corrects obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Thermogenic activation induces FGF21 expression and release in brown adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

European Code against Cancer 4th Edition: Physical activity and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise training in transgenic mice is associated with attenuation of early breast cancer growth in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The myokine decorin is regulated by contraction and involved in muscle hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Decorin suppresses bone metastasis in a breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Revisiting the matricellular concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Decorin: a guardian from the matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Musclin, a novel skeletal muscle-derived secretory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Musclin is an activity-stimulated myokine that enhances physical endurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise capacity and mortality among men referred for exercise testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Delivery of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Fc-based cytokines : prospects for engineering superior therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

gp130 receptor ligands as potential therapeutic targets for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Hepatosplanchnic clearance of interleukin-6 in humans during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Diabetes, insulin and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Regulation of glucose fluxes during exercise in the postabsorptive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

The anti-inflammatory effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Ciliary neurotrophic factor: a role in obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise and the Regulation of Adipose Tissue Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Low brown adipose tissue activity in endurance-trained compared with lean sedentary men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Humoral nature of the hypoglycemic factor of muscular work

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

IL-7 is expressed and secreted by human skeletal muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Parabiosis in mice: a detailed protocol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Exercise capacity and mortality - a follow-up study of 3033 subjects referred to clinical exercise testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2016.153

Role of muscle-derived growth factors in bone formation

31 March 2020

1 reference

12 December 2020

Lack of exercise is a major cause of chronic diseases

1 reference

12 December 2020

Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics

1 reference

12 December 2020

Targeting gp130 to prevent inflammation and promote insulin action.

1 reference

12 December 2020

Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization

1 reference

12 December 2020

Cancer, physical activity, and exercise

1 reference

12 December 2020